Page last updated: 2024-10-21

1-(3-chlorophenyl)piperazine and Amphetamine-Related Disorders

1-(3-chlorophenyl)piperazine has been researched along with Amphetamine-Related Disorders in 4 studies

1-(3-chlorophenyl)piperazine: supposed metabolite of TRAZODONE; RN given refers to parent cpd; structure
1-(3-chlorophenyl)piperazine : A N-arylpiperazine that is piperazine carrying a 3-chlorophenyl substituent at position 1. It is a metabolite of the antidepressant drug trazodone.

Amphetamine-Related Disorders: Disorders related or resulting from use of amphetamines.

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Petrie, MS1
Lynch, KL1
Wu, AH1
Steinhardt, AA1
Horowitz, GL1
Ganetsky, M1
Milone, MC1
Johanson, CE1
Kilbey, M1
Gatchalian, K1
Tancer, M1

Trials

1 trial available for 1-(3-chlorophenyl)piperazine and Amphetamine-Related Disorders

ArticleYear
Discriminative stimulus effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans trained to discriminate among d-amphetamine, meta-chlorophenylpiperazine and placebo.
    Drug and alcohol dependence, 2006, Jan-04, Volume: 81, Issue:1

    Topics: Adult; Alcoholism; Amphetamine-Related Disorders; Arousal; Dextroamphetamine; Discrimination Learnin

2006

Other Studies

3 other studies available for 1-(3-chlorophenyl)piperazine and Amphetamine-Related Disorders

ArticleYear
Prescription compliance or illicit designer drug abuse?
    Clinical chemistry, 2012, Volume: 58, Issue:12

    Topics: Amphetamine-Related Disorders; Antidepressive Agents; Bupropion; Cross Reactions; Designer Drugs; Fa

2012
Commentary.
    Clinical chemistry, 2012, Volume: 58, Issue:12

    Topics: Amphetamine-Related Disorders; Antidepressive Agents; Designer Drugs; Female; Humans; Medication Adh

2012
Commentary.
    Clinical chemistry, 2012, Volume: 58, Issue:12

    Topics: Amphetamine-Related Disorders; Antidepressive Agents; Designer Drugs; Female; Humans; Medication Adh

2012